Dilemmas in access to medicines: a humanitarian perspective – Authors' reply

Lancet 387 (10073):1008-1009 (2017)
  Copy   BIBTEX

Abstract

Our Viewpoint argues that expanding access to less effective or more toxic treatments is supported not only by utilitarian ethical reasoning but also by two other ethical frameworks: those that emphasise equality and those that emphasise giving priority to the patients who are worst off. The inadequate resources available for global health reflect not only natural constraints but also unwise social and political choices. However, pitting efforts to reduce inequality and better fund global health against efforts to put available resources to their best use mistakes complementary objectives for conflicting ones.

Links

PhilArchive

External links

  • This entry has no external links. Add one.
Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Introduction: Access to Life-Saving Medicines and Intellectual Property Rights.Doris Schroeder - 2011 - Cambridge Quarterly of Healthcare Ethics 20 (2):277-278.
Bodies of Rights and Therapeutic Markets.João Biehl & Adriana Petryna - 2011 - Social Research: An International Quarterly 78 (4):359-386.
Bodies of rights and therapeutic markets.João Biehl & Adriana Petryna - 2011 - Social Research: An International Quarterly 78 (2):359-386.
Patent Funded Access to Medicines.Tom Andreassen - 2014 - Developing World Bioethics 15 (3):152-161.

Analytics

Added to PP
2017-03-11

Downloads
347 (#55,798)

6 months
49 (#82,973)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Govind Persad
University of Denver

References found in this work

No references found.

Add more references